Intra Cellular Therapies shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $9.8M | 142k | 69.20 |
| 2023-09-30 | $2.2M | 43k | 52.09 |
| 2023-06-30 | $2.8M | 44k | 63.32 |
| 2023-03-31 | $2.4M | 44k | 54.15 |
| 2022-12-31 | $1.4M | 27k | 52.92 |
| 2022-09-30 | $1.1M | 24k | 46.55 |
| 2022-06-30 | $7.2M | 126k | 57.09 |
| 2022-03-31 | $8.2M | 135k | 61.19 |
| 2021-12-31 | $6.5M | 123k | 52.34 |
| 2021-09-30 | $3.1M | 84k | 37.29 |
| 2021-06-30 | $2.9M | 72k | 40.82 |
| 2021-03-31 | $2.4M | 72k | 33.93 |
| 2020-12-31 | $2.3M | 72k | 31.80 |
| 2020-09-30 | $718k | 28k | 25.65 |